CarbagluActive Ingredient(s): Carglumic Acid
FDA Approved: * March 18, 2010
Pharm Company: * R & R REGISTRATIONS INC
Carglumic acid, sold under the brand name Carbaglu among others, is used for the treatment of hyperammonaemia. Carglumic acid is a carbamoyl phosphate synthetase 1 (CPS 1) activator. The most common adverse effects include vomiting, abdominal pain, pyrexia (fever), and tonsillitis, anemia, diarrhea, ear infection, other infections, nasopharyngitis, decreased hemoglobin levels, and headache. It was a... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Is Carbaglu available in the USA?...